Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes

• Published in: American journal of obstetrics and gynecology Vol. 224; no. 5; pp. 518.e1 - 518.e11
• Main Authors: Lai, Jonathan, Syngelaki, Argyro, Nicolaides, Kypros H., von Dadelszen, Peter, Magee, Laura A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2021
• Subjects: Adult; Alanine Transaminase - blood; angiogenic markers; Aspartate Aminotransferases - blood; Blood Pressure; Chronic Disease; Creatinine - blood; definition; Female; Humans; Hypertension - physiopathology; Liver - physiopathology; Nervous System Diseases - etiology; outcomes; Placenta - physiopathology; Placenta Growth Factor - blood; Platelet Count; Practice Guidelines as Topic; Pre-Eclampsia - diagnosis; Pre-Eclampsia - physiopathology; preeclampsia; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Proteinuria - etiology; Proteinuria - urine; Renal Insufficiency - blood; Renal Insufficiency - etiology; Thrombocytopenia - blood; ultrasound; Vascular Endothelial Growth Factor Receptor-1 - blood; angiogenic markers; definition; preeclampsia; outcomes; ultrasound

Any definition of preeclampsia should identify women and babies at greatest risk of adverse outcomes. This study aimed to investigate the ability of the American College of Obstetricians and Gynecologists and International Society for the Study of Hypertension in Pregnancy definitions of preeclampsi...